Spectrascience Competitors
Analyzing Spectrascience New competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Spectrascience New to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Spectrascience New Correlation with its peers. For information on how to trade Spectrascience Stock refer to our How to Trade Spectrascience Stock guide.
At present, Spectrascience New's Return On Equity is projected to slightly decrease based on the last few years of reporting. At present, Spectrascience New's Total Current Assets are projected to decrease significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 5.10, whereas Other Assets are forecasted to decline to about 88.4 K.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Spectrascience New competition on your existing holdings.
Spectrascience | Build AI portfolio with Spectrascience Stock |
Spectrascience New Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Spectrascience New and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Spectrascience and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Spectrascience New does not affect the price movement of the other competitor.
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Spectrascience Stock performing well and Spectrascience New Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Spectrascience New's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| SVTE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| EHOS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| HAON | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| ABVG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| PDPR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cross Equities Net Income Analysis
Compare Spectrascience New and related stocks such as Service Team, Ehouse Global, and Halitron Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EHOS | (9 K) | (9 K) | (29.5 K) | (262.8 K) | (2.8 M) | (2.8 M) | (2.8 M) | (2.8 M) | (2.8 M) | (2.8 M) | (2.8 M) | (2.8 M) | (2.8 M) | (2.8 M) | (2.5 M) | (2.4 M) |
| ABVG | 1.5 M | (27.4 K) | (27.4 K) | (27.4 K) | (233.8 K) | (135.1 K) | (135.1 K) | (135.1 K) | (135.1 K) | (135.1 K) | (135.1 K) | (135.1 K) | (135.1 K) | (135.1 K) | (121.6 K) | (115.5 K) |
| PDPR | (4.4 M) | (299.6 K) | (299.6 K) | (299.6 K) | (299.6 K) | (299.6 K) | (299.6 K) | (299.6 K) | (299.6 K) | (299.6 K) | (299.6 K) | (299.6 K) | (299.6 K) | (299.6 K) | (344.6 K) | (361.8 K) |
Spectrascience New and related stocks such as Service Team, Ehouse Global, and Halitron Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Spectrascience New financial statement analysis. It represents the amount of money remaining after all of Spectrascience New operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Spectrascience New Competitive Analysis
The better you understand Spectrascience New competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Spectrascience New's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Spectrascience New's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
| SVTE | HAON | PDPR | |
| 0.00 0.0001 Service | 0.00 0.0001 Halitron | 0.00 0.0001 Marathon | Market Volatility (90 Days Market Risk) |
| Market Performance (90 Days Performance) | |||
| Odds of Financial Distress (Probability Of Bankruptcy) | |||
| Current Valuation (Equity Enterprise Value) | |||
| Buy or Sell Advice (Average Analysts Consensus) | |||
Trade Advice (90 Days Macroaxis Advice) | |||
| Current Ratio | |||
| Net Asset | |||
| Profit Margin | |||
| EBITDA | |||
| Current Valuation | |||
| Operating Margin | |||
| Price To Book | |||
| Retained Earnings | |||
| Current Asset | |||
| Beta | |||
| Number Of Employees | |||
| Shares Outstanding | |||
| Cash Flow From Operations | |||
| Total Debt | |||
| Return On Equity | |||
| Z Score | |||
| Return On Asset | |||
| Book Value Per Share | |||
| Current Liabilities | |||
| Total Asset | |||
| Debt To Equity | |||
| Market Capitalization | |||
| Price To Earning | |||
| Price To Sales | |||
| Net Income | |||
| Earnings Per Share | |||
| Shares Owned By Insiders | |||
| Revenue | |||
| Working Capital | |||
| Cash And Equivalents | |||
| Cash Per Share | |||
| Gross Profit | |||
| Rate Of Daily Change | |||
| Day Median Price | |||
| Day Typical Price |
Spectrascience New Competition Performance Charts
Five steps to successful analysis of Spectrascience New Competition
Spectrascience New's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Spectrascience New in relation to its competition. Spectrascience New's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Spectrascience New in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Spectrascience New's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Spectrascience New, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Spectrascience New position
In addition to having Spectrascience New in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Asset Allocation ETFs Thematic Idea Now
Asset Allocation ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Asset Allocation ETFs theme has 164 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Asset Allocation ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Spectrascience New Correlation with its peers. For information on how to trade Spectrascience Stock refer to our How to Trade Spectrascience Stock guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Spectrascience New. If investors know Spectrascience will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Spectrascience New listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Spectrascience New is measured differently than its book value, which is the value of Spectrascience that is recorded on the company's balance sheet. Investors also form their own opinion of Spectrascience New's value that differs from its market value or its book value, called intrinsic value, which is Spectrascience New's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Spectrascience New's market value can be influenced by many factors that don't directly affect Spectrascience New's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Spectrascience New's value and its price as these two are different measures arrived at by different means. Investors typically determine if Spectrascience New is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Spectrascience New's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.